期刊文献+

香菇六糖的脱保护反应研究及表征 被引量:1

Study on Deprotection Reaction and Characterization of Lentinan
下载PDF
导出
摘要 对香菇六糖的脱保护反应进行工艺改进,使收率提高至96.8%,含量达到99.89%,并对所获得的香菇六糖进行了1 HNMR、13 CNMR、MS表征。为香菇六糖的进一步研究奠定了基础。 In this article, the deprotection reaction of lentinan was improved, the yield and the content of lentinan reached 96. 8% and 99. 89%, respectively. Lentinan was characterized by ^1HNMR,^13CNMR, MS. This study provides the foundation for further research of lentinan.
出处 《化学与生物工程》 CAS 2013年第8期61-62,共2页 Chemistry & Bioengineering
关键词 香菇六糖 脱保护反应 表征 lentinan deprotection reaction characterization
  • 相关文献

参考文献8

  • 1Chihara G. Immunopharmacology of lentinan, a polysaccharide i- solated from Lentinus edodes :Its application as a host defence po- tentiator[J]. Int J Orient Med, 1992,17:55-77.
  • 2Suzuki I, Hashimoto K, Oikawa S, et al. A galloylated monoter- pene glucoside and dimeric monomeric and trimeric hydrolysable related tannins[J]. C hem Pharm Bull, 1989,37 : 410.
  • 3Wittinghofer F, Krengel U, John J, et al. Three-dimensional struc- ture of p21 in the active conformation and analysis of an oncogenic mutant[J]. Immumopharmacol, 1991,93:11-15.
  • 4Chihara G, Hamuro J, Maeda Y, et al. Antitumor polysaccharide derived chemically from natural glucan (paehyman)[J]. Nature, 1970,225(5236):943-944.
  • 5Adachi K,Nanba H,Kuroda H. Potentiation of host-mediated an- titumor activity in mice by beta-glucan obtained from Grifola frondosa,(maitake) [J]. Chem Pharm Bull, 1987,35(1) :262-270.
  • 6de Vere White R W, Hackman R M, Soares S E, et al. Effects of a mushroom mycelium extract on the treatment of prostate cancer [J]. Urology,2002,60(4) :640-644.
  • 7张志平,衣悦涛,宁君.香菇多糖核心片段六糖的合成研究[J].有机化学,2005,25(10):1240-1243. 被引量:6
  • 8宁君,孔繁祚.香菇多糖核心片段三糖,四糖,六糖,七糖的合成[P].CN1303857,2001-07-18.

二级参考文献30

  • 1Chihara, G. Int. J. Orient. Med. 1992,17,57.
  • 2Ochiai, T.; Isono, K.; Suzuki, T.; Koide, Y.; Gunji, Y.; Nagata, M.; Ogawa, N. Int. J. Immunother. 1992, 8, 161.
  • 3Adachi, K.; Nanba, H.; Kuroda, H. Chem. Pharm. Bull.1987, 35, 262.
  • 4Suzuki, I.; Hashimoto, K.; Oikawa, S.; Sato, K.; Osawa, M.;Yadomae, T. Chem. Pharm. Bull. 1989, 37, 410.
  • 5Jong, S. C.; Birmingham, J. M.; Pai, S. H. J. Immunol. Immumopharmacol. 1991, 11, 15.
  • 6Mizuno, T. Intern. J. Med. Mush. 1999, 1, 9.
  • 7Chihara, G.; Hamuro, J.; Maeda, Y.; Arai, Y.; Fukuoka, F.Nature 1970, 225, 943.
  • 8de Vere White, R. W.; Hackman, R. M.; Soares, S. E.;Beckett, L. A.; Sun, B. Urology 2002, 60(4), 640.
  • 9Sasaki, T.; Takasuka, N. Carbohydr. Res. 1976, 47, 99.
  • 10Hamuro, J.; Chihara, G. In Immune Modulation Agents and Their Mechanisms, Eds.: Fenichel, R. L.; Chirigos, M. A.,New York, Marcel Dekker, 1985, pp. 409~436.

共引文献5

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部